Bdbrut 140 Mg Capsules

Bdbrut Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Strength140 mg
Pack Size1*30 Capsules
ManufacturerBDR Pharmaceuticals Internationals Pvt
TreatmentMantle-cell lymphoma and blood cancer
Brand NameBdbrut
Generic NameIbrutinib 140mg
CompostionIbrutinib
Country of originMade in India
FormCapsule

Description

Bdbrut Capsule is used in the treatment of mantle-cell lymphoma and blood cancer (chronic lymphocytic leukemia). It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy.

Bdbrut Capsule is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your response to treatment. Your doctor may get regular blood tests to check number of blood cells during treatment with this medicine. It is known to reduce the number of blood cells in your blood thereby, increasing the susceptibility to infections.  It may cause headache, diarrhea, and nausea as its side effects.

Chronic lymphocytic leukemia (CLL) is a slow-growing blood cancer in which the bone marrow makes abnormal white blood cells that crowd out healthy cells and weaken the immune system. Bdbrut Capsule helps block signals that cancer cells need to grow and multiply, slowing disease progression and supporting healthier blood cell balance. This helps manage symptoms, maintain immune function, and improve quality of life.
Bdbrut Capsule is a Bruton’s tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Bdbrut Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Bdbrut Capsule should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

We have strong global networks in Africa, Europe, United Kingdom, United States, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, Unites Arab Emirates, Thailand, Vietnam, Middle East and South East Countries.

Explore more products anti cancer

Additional information

Strength

140 mg

Pack Size

1*30 Capsules

Manufacturer

BDR Pharmaceuticals Internationals Pvt

Treatment

Mantle-cell lymphoma and blood cancer

Brand Name

Bdbrut

Generic Name

Ibrutinib 140mg

Compostion

Ibrutinib

Country of origin

Made in India

Form

Capsule

Reviews

There are no reviews yet.

Be the first to review “Bdbrut 140 Mg Capsules”

Your email address will not be published. Required fields are marked *